Nectar Lifescience Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 6.62 | 7.58 | 35.46 |
| Operating Expense | 27.68 | 89.23 | 1.92 |
| Net Profit | -13.14 | -67.92 | 14.27 |
| Net Profit Margin | -198.49% | -896.04% | 40.24% |
| Earning Per Share | -2.21 | -3.38 | 0.64 |
| EBIDTA | -12.87 | -61.94 | 44.55 |
| Effective Tax Rate | -0% | -0% | 0% |
Particulars
Jun 2026
Revenue6.62
Operating Expense27.68
Net Profit-13.14
Net Profit Margin-198.49
Earning Per Share-2.21
EBIDTA-12.87
Effective Tax Rate-0
